Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma
Authors:
- 1 December 2000
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (12) , 2733-2742
Abstract
Objective To examine domain recognition by anti–DNA topoisomerase I (anti–DNA topo I, or anti–topo I) antibodies over time in scleroderma patients. Methods Serial serum samples from scleroderma patients with known reactivity to Scl‐70, a 70‐kd topo I breakdown product, were tested by immunoblot for IgM, IgG, IgA, κ, and λ reactivity to Scl‐70 and 8 overlapping recombinant peptide fragments (F1–F8) that span the human topo I molecule. Results IgM, IgG, κ, and λ anti–topo I antibodies in both early‐disease and late‐disease serum samples preferentially recognized the Scl‐70 molecule rather than the F1–F8 peptides, suggesting preferential recognition of conformational determinants on Scl‐70 throughout the disease course. Amounts of both primary and secondary anti–topo I antibodies to Scl‐70 varied over time, including increases in primary antibody responses late in the disease course. Striking variability in recognition of the F1–F8 peptides by IgM, IgG, IgA, κ, and λ anti–topo I antibodies was seen in serial samples. Most often, the change in FI–F8 recognition from one sample to the next was unpredictable, although occasionally patterns of antibody recognition were reciprocal in serial samples. Of note, in several patients, what could have been interpreted as domain spreading among F1–F8 in 2 successive samples was just a part of changing antibody reactivity to these peptides that again became more restricted in a third sample. Conclusion Titers and immunodominant domains recognized by both primary and secondary anti–topo I antibodies are highly variable over time. This suggests continual antigen presentation and regulation of the anti–topo I antibody response in scleroderma, even late in the disease course.Keywords
This publication has 28 references indexed in Scilit:
- Detection of Anti-DNA Topoisomerase I Antibody by an Enzyme-Linked Immunosorbent Assay Using Overlapping Recombinant PolypeptidesClinical Immunology and Immunopathology, 1995
- Immune responses against multiple epitopesJournal of Theoretical Biology, 1995
- Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity.Journal of Experimental Medicine, 1995
- Autoantibodies in Systemic SclerosisInternational Reviews of Immunology, 1995
- Regulation of B Cell Tolerance and Triggering by Immune Complexes1994
- IDENTIFICATION OF A UNIVERSAL B CELL EPITOPE ON DNA TOPOISOMERASE I, AN AUTOANTIGEN ASSOCIATED WITH SCLERODERMAArthritis & Rheumatism, 1993
- Connective Tissue Disease and Autoantibodies in the Kindreds of 63 Patients with Systemic SclerosisMedicine, 1993
- Analysis of anti-idiotypic antibodies against anti-microsomal antibodies in patients with thyroid autoimmunityJournal of Autoimmunity, 1992
- A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosisClinical and Experimental Immunology, 1990
- Clinical associations of anticentromere antibodies and antibodies to topoisomerase i. a study of 355 patientsArthritis & Rheumatism, 1988